Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US11179403B2 · kind B2 · utility
4Cited by
60References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2019 |
| Grant date | Nov 23, 2021 |
| Priority date | — |
| Expiry date | Oct 17, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.